etomethazene cas: 10177-54-3

CAS NO: 10177-54-3
Our products are for scientific research use only
Chemical Name: Etomethazene
Molecular Formula: C23H24N2O2
Formula Weight: 360.45 g/mol
CAS No: 10177-54-3
Description Review
Description
Our products are for scientific research use only

Etomethazene is a synthetic opioid analgesic drug used for the relief of moderate to severe pain. This drug is not commonly used in clinical practice due to its high potency, which can cause respiratory depression and other side effects, making it useful mainly as a veterinary analgesic. In this article, we will discuss the chemical properties, health benefits, potential effects, mechanisms, safety, side-effects, and dosage of etomethazene.

Chemical Properties: Etomethazene is a synthetic opioid agonist that belongs to the ethyl-morphine family. The molecular formula of etomethazene is C23H24N2O2, and its molecular weight is 360.45 g/mol. This drug is a white to off-white crystalline powder that is soluble in water and methanol. Like other opioids, etomethazene works by binding to the mu opioid receptors in the brain, spinal cord, and other parts of the body.

Health Benefits: Etomethazene is a potent analgesic drug that provides pain relief by acting on the central nervous system. This drug is mainly used in veterinary medicine to manage post-operative pain in dogs and cats. Etomethazene has also been reported to be effective in treating pain associated with bone fractures, cancer, and other chronic conditions in humans, but its use in humans is limited due to its high potency and potential side effects.

Potential Effects: The effects of etomethazene are similar to other opioid drugs, including pain relief, sedation, euphoria, and respiratory depression. It is important to note that etomethazene is a potent drug, and overdose can lead to serious side effects, including coma and death.

Mechanisms: Etomethazene works by binding to the mu opioid receptors in the brain and spinal cord, producing analgesia and other effects on the central nervous system. This drug also produces sedation, respiratory depression, and other side effects by affecting other areas of the brain.

Safety: Etomethazene is a potent drug that should only be used under the supervision of a veterinarian or qualified healthcare professional. This drug should not be used in patients with a history of allergic reactions to opioid drugs, respiratory depression, or other medical conditions that may be aggravated by opioids. Etomethazene should also be used with caution in patients with a history of drug or alcohol abuse, as these patients may be more susceptible to the side effects of opioids.

Side-Effects: The side effects of etomethazene are similar to those of other opioid drugs, including respiratory depression, sedation, dizziness, nausea, vomiting, and constipation. Overdose of etomethazene can lead to serious side effects, including coma, seizures, and death. It is important to consult with a healthcare professional or veterinarian prior to administering this drug to minimize the risk of adverse reactions.

Dosage Information: The dose of etomethazene varies depending on the patient's weight, medical condition, and other factors. This drug is typically administered via injection, and the dose should be carefully titrated to achieve the desired level of pain relief while minimizing the risk of side effects. It is important to follow the dosage instructions provided by a healthcare professional or veterinarian to ensure safe and effective use of this drug.

In conclusion, etomethazene is a potent opioid analgesic drug used primarily for veterinary purposes to manage post-operative pain in dogs and cats. While it may be effective in treating pain associated with bone fractures, cancer, and other chronic conditions in humans, its use is limited due to its high potency and potential for side effects. Etomethazene should only be used under the supervision of a qualified healthcare professional or veterinarian to ensure safe and effective use.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us